
Full year report 2021 (January-December 2021)
2022-02-10 @ 08:00
Report will be released at 8.00am CET and conference call at 10.00am CET
Report will be released at 8.00am CET and conference call at 10.00am CET
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.
Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)
Download our fact sheet: Ascelia Pharma Factsheet Dec 2020